Abound Wealth Management’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$99 Hold
5
– – ﹤0.01% 1351
2026
Q2
$129 Hold
5
– – ﹤0.01% 1229
2026
Q1
$103 Hold
5
– – ﹤0.01% 1404
2025
Q4
$119 Hold
5
– – ﹤0.01% 1354
2025
Q3
$125 Hold
5
– – ﹤0.01% 1271
2025
Q2
$115 Hold
5
– – ﹤0.01% 1220
2025
Q1
$113 Sell
5
-5
-50% -$116 ﹤0.01% 1207
2024
Q4
$196 Hold
10
– – ﹤0.01% 1078
2024
Q3
$183 Sell
10
-1
-9% -$19 ﹤0.01% 1220
2024
Q2
$192 Hold
11
– – ﹤0.01% 1113
2024
Q1
$216 Hold
11
– – ﹤0.01% 1227
2023
Q4
$254 Buy
+11
New +$246 ﹤0.01% 1229

Other funds holding PRVA

Abound Wealth Management's PRVA Position: Q3 2026 in Review

Abound Wealth Management held its Privia Health (PRVA) position steady in Q3 2026 at 5 shares worth $99. The position accounts for ﹤0.01% of the portfolio, ranked #1351.

Abound Wealth Management first reported a position in PRVA in Q4 2023 and has held it in 12 quarters since. The position peaked at $254 in Q4 2023. 74 funds tracked by Wall St. Rank hold PRVA as of Q3 2026.

  • Abound Wealth Management held 5 shares of Privia Health worth $99 as of Q3 2026.
  • Abound Wealth Management left its Privia Health share count unchanged in Q3 2026.
  • Privia Health made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #1351 holding.
  • Abound Wealth Management first reported a position in Privia Health in Q4 2023 and has held it in 12 quarters since.
  • Abound Wealth Management's Privia Health position peaked at $254 in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Privia Health as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.